Merger

Recorded: 2016-09-20 Pages: 4

Assignor

XETRIOS THERAPEUTICS, INC.

Executed: 2016-08-09

Assignee

KOLLTAN PHARMACEUTICALS, INC.

300 GEORGE STREET, SUITE 530, NEW HAVEN, CONNECTICUT, 06511

Covered Property (1)

Regulating the Interaction Between Tam Ligands and Lipid Membranes with Exposed Phosphatidyl Serine

Application: 14/416,801 →

Publication: US 2015/0164800

Related Assignments (2)

Other recorded transfers of the patent in this record — the chain of ownership.